Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Etta Biotech logo — Empowering researchers to innovate with precision electropor...

Etta Biotech

Empowering researchers to innovate with precision electroporation technology for advanced cell study and control.

Founded 2014 Series A Total: $290.00K Health Care, Manufacturing

General Information

Company Name Etta Biotech
Founded Year 2014
Industries Health Care, Manufacturing
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Etta Biotech. To contact Etta Biotech, visit ettabiotech.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Etta Biotech compare?

A PDF of Etta Biotech and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Etta Biotech soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Etta Biotech

Etta Biotech is a cutting-edge startup in the health care and manufacturing industries, with a mission to empower researchers through precision electroporation technology. The company, founded in 2014, specializes in designing and producing electroporation equipment and essential supplies for research specialists. Their innovative solutions fill a gap in the market for home-based electrotransfection tools, supporting researchers in controlling and studying cell characteristics. One of their standout products is the X-Porator F1 flow electroporation device, which can process 250 ml of cell fluid and achieve an impressive transfection rate. This disruptive technology has attracted significant attention and investment, with their Series A round garnering a substantial $290.00K funding from Bison Capital on 23 November 2018. Etta Biotech's focus on advancing cell study and control, coupled with their successful fundraising efforts, positions them as a promising player in the biotech and research equipment space. With the support of Bison Capital and their commitment to innovation, Etta Biotech is well-positioned to make a lasting impact in the field of electroporation technology.

Business keywords: precision electroporation technology, cell study, cell control, research equipment, electroporation devices, research tools, home-based electrotransfection tools, X-Porator F1, research specialists, cell characteristics, transfection rate, research supplies, electrotransfection apparatus

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $290.00K 1
Bison Capital Asset Management
23 Nov 2018

Etta Biotech Alternatives & Competitors

View All Alternatives
Etta Biotech vs
Prolific Machines
Prolific Machines United States

Illuminating biology's limitless potential

Series B
65 employees
Biotechnology, Health Care
Etta Biotech vs
OMS Your Dental Unitness
OMS Your Dental Unitness Italy

60 years of Italian style design serving dentists and their teams.

4 employees
Health Care, Manufacturing
Etta Biotech vs
Apyx Medical
Apyx Medical United States

Energy Elevating Lives

Post-IPO Debt
141 employees
Health Care, Manufacturing
View all alternatives

FAQ About Etta Biotech

Empowering researchers to innovate with precision electroporation technology for advanced cell study and control.
Etta Biotech was founded in 2014.
Etta Biotech operates in Health Care and Manufacturing. Its work centres on precision electroporation technology, cell study, cell control and research equipment.
Etta Biotech has completed 1 funding round, raising a total of $290.00K. The latest funding stage is Series A.
Top alternatives and competitors to Etta Biotech include Prolific Machines, OMS Your Dental Unitness, Apyx Medical, MedEnvision, Spring Health Products. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Etta Biotech and Prolific Machines are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Etta Biotech, https://bouncewatch.com/company/etta-biotech, updated 28 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes